📜5-[(3,4-二氢-4-氧代-1-酞嗪基)甲基]-2-氟苯甲酸,1-乙酰哌嗪置于o-(1H-Benzotriazol-1-yl)-N,N,N',N'-Tetramethyluronium Hexafluorophosphate,N,N-二异丙基乙胺体系中,用 N,N-二甲基乙酰胺 作为反应溶剂,化学反应生成 奥拉帕尼杂质58
参考文献:4-[3-(4-Cyclopropanecarbonylpiperazine-1-Carbonyl)-4-Fluorobenzyl]-2H-Phthalazin-1-One: A Novel Bioavailable Inhibitor Of Poly(Adp-Ribose) Polymerase-1
标题:4-[3-(4-Cyclopropanecarbonylpiperazine-1-Carbonyl)-4-Fluorobenzyl]-2H-Phthalazin-1-One: A Novel Bioavailable Inhibitor Of Poly(Adp-Ribose) Polymerase-1
摘要:Poly(Adp-Ribose) Polymerase Activation Is An Immediate Cellular Response To Metabolic-,Chemical-,Or Ionizing Radiation-Induced Dna Damage And Represents A New Target For Cancer Therapy. In This Article,We Disclose A Novel Series Of Substituted 4-Benzyl-2H-Phthalazin-1-Ones That Possess High Inhibitory Enzyme And Cellular Potency For Both Parp-1 And Parp-2. Optimized Compounds From The Series Also Demonstrate Good Pharmacokinetic Profiles,Oral Bioavailability,And Activity In Vivo In An Sw620 Colorectal Cancer Xenograft Model. 4-[3-(4-Cyclopropanecarbonylpiperazine-1-Carbonyl)-4-Fluorobenzyl]-2H-Phthalazin-1-One (Ku-0059436,Azd2281) 47 Is A Single Digit Nanomolar Inhibitor Of Both Parp-1 And Parp-2 That Shows Standalone Activity Against Brca1-Deficient Breast Cancer Cell Lines. Compound 47 Is Currently Undergoing Clinical Development For The Treatment Of Brca1-And Brca2-Defective Cancers.
DOI:10.1021/jm8001263